| HOME >> BIOLOGY >> TECHNOLOGY |
"In these challenging times, Scotland's world-class talent, high-tech infrastructure and commitment to cross-sector collaboration provide a rich and innovative environment for life science investors," said Rhona Allison, Senior Director Life Sciences, Scottish Enterprise. "Major capital investments such as the new Edinburgh BioQuarter and the Scottish Centre for Regenerative Medicine -- led by Sir Ian Wilmut -- are only a few examples of how Scotland is helping companies quickly and effectively bring novel technologies and products to market."
Earlier this year, Scottish companies and organizations achieved stem cell breakthroughs in synthetic blood and embryonic and iPS (Induced pluripotent stem cells) technology and began stem cell clinical trials for corneal blindness and stroke, further reinforcing Scotland's world-leading position in the use of stem cell-based therapies. At BIO, government-sponsored innovation fund ITI Life Sciences and stem cell company Cellartis AB will offer insights into the company's new license to produce large volumes of high-quality, ethically-derived human embryonic stem cell lines (hES) and expand Scottish operations. NovaBiotics, one of Scotland's leading biotech companies focused on the design and development of antifungal and antibacterial therapeutics, will also be on hand to discuss the development of its lead product Novexatin(TM), a novel treatment for fungal nail infection.
Scottish Organizations at BIO
Accuro Biologics
Aquapharm Biodiscovery Ltd
AvantiCell Science Ltd
BioFilm Limited
BioOutsource
Biotech Innovation and Future Health Limited
Cellartis AB
ClinTec International Ltd
CXR Biosciences Ltd
Devro Medical Limited
Environmental Hygiene Products Ltd
Equatec
Fulcrum
'/>"/>
| SOURCE Scottish Enterprise Copyright©2009 PR Newswire. All rights reserved |